CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Overcoming oncolysis resistance by double infections with vaccine-derived state-of-the-art virotherapeutics
DOI 10.1055/s-0033-1352716
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Meinhardt, M Zimmermann, J Sturm, NP Malek, M Bitzer, RJ Aguilar, NG Chen, AA Szalay, UM Lauer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Virotherapy is a promising new approach in cancer therapy. However, in prior work we have identified tumor cell lines originating from colon (HCT-15, KM12) or renal (ACHN) cancer exhibiting a primary resistance towards vaccine-derived virotherapeutics (vaccinia virus, VACV; measles vaccine virus, MeV); variants of both viruses are currently tested in clinical phase I/II trials (e.g., NCT01443260 & NCT0…
Zitieren
Zitierempfehlung
M Meinhardt, M Zimmermann, J Sturm, NP Malek, M Bitzer, RJ Aguilar, NG Chen, AA Szalay, UM Lauer (2013) Overcoming oncolysis resistance by double infections with vaccine-derived state-of-the-art virotherapeutics. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352716
Mit CareLit weiterarbeiten